Monopar Therapeutics MNPR Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATXGATX

$1.75M+243%

CarGurus, Inc.CARG

-$613K-186%

Achieve Life SciencesACHV

$4K—

ADTRAN Holdings, Inc.ADTN

-$2.56M-2,024%

SPS CommerceSPSC

$288K-56.4%

SeaboardSEB

$0-100%

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M-62.2%

Net income-$3.9M-48.3%

EPS (diluted)-$0.19—

Balance sheet

See full

Cash & equivalents$52.5M+32.3%

Total debt$230.4K+2,692%

Total equity$135.4M+153%

Total assets$138.0M+150%

Cash flow

See full

Operating cash flow-$3.5M+38.7%

Valuation

See full

Market cap$587.04M+192%

Enterprise value$534.72M+232%

Returns & leverage

See full

Return on equity-15.9%-6.6pp

Debt / equity0×0.0×

Current ratio56×—

Where this comes from

Reported directly by Monopar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monopar Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?: Monopar Therapeutics (MNPR) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$31.63K in Q1 2026.
How has Monopar Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?: Monopar Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 58470.4% year-over-year, from -$54 to -$31.63K.